INTRODUCTION
Cross-sectional imaging strongly influences the diagnosis and management of several pathologic entities including liver lesions, pulmonary nodules, and gastrointestinal (GI) hemorrhage. Often, patients will have pre procedure cross-sectional imaging that guides the management plan. While high-quality computed tomography (CT) and magnetic resonance imaging (MRI) offer excellent sensitivity and specificity for detecting lesions and characterizing vascular anatomy, accuracy depends on the quality of images obtained, and the accuracy with which they are interpreted. Conventional angiography can provide additional diagnostic and anatomic vascular information that may not have been apparent on pre procedure imaging. Characteristic angiography findings of liver lesions include vascular proliferation, tumor staining, mass effect, and arteriovenous shunting; the distribution and magnitude of vascular changes can aid in diagnosis and prognosis. [1] Conventional angiography also serves to define the vascular anatomy, evaluate the extent of disease, and help assess the viability of surgical resection in candidates. [2] Unexpected angiographic findings prompt the Interventionalist to alter or abort the management plan during the procedure. Examples of possible unexpected findings include previously undetected lesions, unanticipated or aberrant vascular supply to lesions, and additional diagnostic information. In these situations, the interventionalist may have to expand the region of embolization, alter the approach, perform additional procedures at a later date, attempt alternative routes or abort the procedure, and change the management plan to surgical or medical treatment modalities.
PREVIOUSLY UNDETECTED LESIONS: LIVER-DIRECTED THERAPY
Liver-directed therapy with transarterial chemoembolization (TACE) and radioembolization (TARE) is a mainstay of primary and secondary liver cancer treatment. Pre procedure imaging with CT and MRI is standard and aids in the detection of tumors and in planning for transarterial intervention.
The reported sensitivity and specificity of CT and MRI for detection of hepatocellular carcinoma (HCC) are 80-100% and 90-95%, respectively, when including all sizes of tumors but decrease significantly for tumors 1-2 cm and decrease even further for tumors <1 cm. [3] In the evaluation of liver metastases, cross-sectional imaging has been shown to be 90-100% sensitive when including all sizes of tumors, but this again decreases significantly for tumors <1 cm. [4] Despite reported accuracy of cross-sectional imaging, unanticipated tumors are frequently encountered during arteriography preceding therapy [ Figures 1-3 ]. Not only this information is diagnostic and useful in altering the therapeutic plan by detecting additional lesions, but also it aids in prognostication. 
UNANTICIPATED VASCULAR SUPPLY TO TARGET LESIONS
Liver tumors, especially HCC, rely heavily on angiogenesis for growth and survival. The ability of such tumors to develops new, abnormal vascular supply may confound efforts to treat them. Aberrant vascular supply can be from extrahepatic vessels such as the inferior phrenic artery or intercostal arteries [5] and branches of the internal mammary artery [ Figure 4 ]. It is important to recognize these other sources when performing TACE/TARE.
In certain cases, tumors may not have a vascular supply conducive to intra-arterial therapy [ Figures 5 and 6 ]. This (c) Angiography demonstrated that the bowel was supplied by the celiac artery via the gastroduodenal artery, via the pancreaticoduodenal arcade, precluding gastroduodenal artery embolization. However, the right and left hepatic arteries and gastroduodenal artery originated from the common hepatic artery in a trifurcation (black arrow), raising concern for nontarget embolization to the bowel from yttrium-90 embolization of either hepatic artery since the gastroduodenal artery (black arrowhead) supplied the superior mesenteric artery distribution due to superior mesenteric artery occlusion (black asterisk). (d) Therefore, a Surefire catheter (Surefire Medical Inc., Westminster, CO, USA; black arrow) was used to prevent retrograde flow of the yttrium-90 embolic agent during embolization. (e) Single-photon emission computed tomography imaging showed delivery to the liver parenchyma without activity in the bowel. can be due to several factors: multiple prior TACE procedures that disrupt the vascular supply in such a way that a vascular approach is unfeasible; inability to traverse stenosis or occlusion of the main vascular supply; or vasculature distribution that involves other organ systems such as the bowel. In these cases, alternative approaches are considered including percutaneous and intraoperative ablation.
ABERRANT VASCULAR ANATOMY
Arterial and venous anatomy is variable among individuals. Variation in origin, number, and course of arteries and veins is common. It is important to identify anatomic variation as it may alter the treatment plan. For liver-directed therapy, replaced and accessory hepatic arteries will alter treatment strategies [ Figure 7 ].
For uterine fibroid embolization, the ovarian artery can often supply the fibroid(s), especially in patients with large fundal fibroids, tubo-ovarian pathology, or prior pelvic surgery [ Figure 8 ]. [6] At times, the supply may not be visible until after the embolization is performed, with a resultant change in flow dynamics and redistribution of flow to the ovarian artery. [6] 
ADDED DIAGNOSTIC INFORMATION FROM ANGIOGRAPHY
While CT and MRI are helpful in differential diagnostic considerations, angiography provides dynamic information Celiac and superior mesenteric arteriography unexpectedly demonstrated scattered stenoses (black arrowheads), aneurysms (black arrows), and arterial dissections, in a pattern consistent with segmental arterial mediolysis. The procedure was stopped, as it was now recognized that the patient was not amenable to endovascular intervention.
that, by showing the evolution of blood flow over time, can help to sort through the differential diagnosis.
CT and MRI are helpful in the diagnosis of hepatic tumors, and in differentiating among the diagnostic considerations. Angiography provides dynamic information that, by showing the propagation of blood flow over time, can help to sort through the differential diagnosis. In the liver, arterioportal and arteriovenous shunts can be revealed that are only suggested or not demonstrated on cross-sectional imaging. Such shunting can suggest particular tumors such as HCC or certain metastases. From a procedural standpoint, arteriovenous shunting influences the dose of radioembolization therapy can be delivered. Arteriovenous shunting is also associated with poor prognosis. [7] In the lung, parenchymal lesions on CT tend to enhance, without focal detail in regard to vascular anatomy. Pulmonary arteriovenous malformations (AVMs), the majority associated with Osler-Weber-Rendu syndrome, often displays tortuous feeding arteries, aneurysms, and dilated draining veins which may be seen on CT. However, other pulmonary arterial or venous diseases such as pseudoaneurysms and mass lesions can be difficult to distinguish at times [ Figures 9 and 10 ]. Sensitivity and specificity of CT for detecting AVMs are 83% and 78% for the whole lung and 72% and 93% for lobar evaluations, respectively, whereas pulmonary arteriography has a sensitivity and specificity of 70% and 100% for the whole lung and 68% and 100% for lobar evaluation, respectively. [8] Beyond providing higher specificity, transcatheter pulmonary arteriography allows for simultaneous diagnosis and management.
Conventional angiography remains the modality of choice to demonstrate subtle vascular lesions. For GI bleeds, endoscopic evaluation is generally performed first. However, if endoscopy is unable to identify the source of bleeding, either because no bleeding is found or excess bleeding prevents localization, angiography can play diagnostic and therapeutic roles. The location of active GI bleeding is identified by extravasation of contrast into the bowel lumen and can be seen at bleeding rates as low as 0.5 mL/h. Angiodysplasias, virtually invisible by axial computerized imaging, can be identified by the tortuous network of vessels and dilated, rapidly draining vein (s). Vasculopathies, such as fibromuscular dysplasia (FMD) and segmental arterial mediolysis (SAM), can be identified as well. FMD, most commonly affecting the renal and cerebral arteries, but occasionally the mesenteric vessels, has three major subtypes affecting different layers of the arterial wall; the most common type, which involves the medial layer, gives a classic "string-of-beads" sign with alternating dilations and stenosis. [9] SAM, classically affecting the splanchnic vessels, is due to the lysis of the outer media of the arteries and characterized by segmental, scattered aneurysms, stenosis, and occlusions with the main distinguishing feature being the high prevalence of dissecting aneurysms [ Figure 11 ]. [10] SAM and FMD have some overlapping histological and radiographic appearances and may be a spectrum of one disease.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
